IL-15-armored CAR-T cells
MM IL-15-Armored CAR-T
Phase 2 mab active
Quick answer
IL-15-armored CAR-T cells for Relapsed/Refractory Multiple Myeloma is a Phase 2 program (mab) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Relapsed/Refractory Multiple Myeloma
- Phase
- Phase 2
- Modality
- mab
- Status
- active